SPX4,207.27-2.97 -0.07%
DIA333.71+0.51 0.15%
IXIC12,779.91-74.89 -0.58%

Ionis Pharmaceuticals Says Phase 2b Study of Investigational Drug Met Primary Endpoint in End-Stage Renal Disease Patients

Ionis Pharmaceuticals Says Phase 2b Study of Investigational Drug Met Primary Endpoint in End-Stage Renal Disease Patients

MT Newswires · 07/28/2022 07:25

Please log in to view news